AFMD - יחס חוב להיוון בספרים affimed.com

Strict FDA oversight and antibody patent protection create significant regulatory barriers for Affimed (AFMD). The historical debt-to-market cap ratio visualizes these risks, where 0.00 shows the current value of the metric. Winning the immunotherapy race requires speed in drug delivery, while business resilience depends on having sufficient capital to complete platform testing.

This ratio determines the proportion of borrowed funds within the equity structure, measuring the issuer's financial autonomy. By analyzing the relationship between the company's total debt and book value of equity, an investor distinguishes fundamental stability from market noise. An increase in this metric signals default risks, while a decrease indicates capitalization. For Affimed (AFMD), this balance is critical when financing the environmental modernization of laboratories. Resource optimization requires stable leverage.